Levodopa reduces risk factors for vascular disease in parkinsonian patients

被引：0
|
作者：
G. Scigliano
G. Ronchetti
F. Girotti
M. Musicco
机构：
[1] Istituto Nazionale Neurologico “C. Besta”,Institute of Biomedical Technologies
[2] National Research Council,undefined
[3] Fondazione S. Lucia,undefined
[4] Istituto Nazionale Neurologico “C. Besta”,undefined
来源：
Journal of Neurology | 2008年 / 255卷
关键词：
Levodopa; Daily Levodopa Dose; Inhibit Norepinephrine Release; Post Ganglionic Sympathetic Nerve;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Amantadine in parkinsonian patients unresponsive to levodopa: A pilot study
    Colosimo, C
    Merello, M
    Pontieri, FE
    JOURNAL OF NEUROLOGY, 1996, 243 (05) : 422 - 425
  • [22] LEVODOPA PHARMACOKINETICS AND PHARMACODYNAMICS IN FLUCTUATING PARKINSONIAN-PATIENTS
    NUTT, JG
    WOODWARD, WR
    NEUROLOGY, 1986, 36 (06) : 739 - 744
  • [23] Levodopa in plasma correlates with body weight of parkinsonian patients
    Müller, T
    Woitalla, D
    Saft, C
    Kuhn, W
    PARKINSONISM & RELATED DISORDERS, 2000, 6 (03) : 171 - 173
  • [24] PHARMACODYNAMICS OF THE HYPOTENSIVE EFFECT OF LEVODOPA IN PARKINSONIAN-PATIENTS
    IRWIN, RP
    NUTT, JG
    WOODWARD, WR
    GANCHER, ST
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (05) : 365 - 374
  • [25] Risk factors for vascular disease and dementia
    Breteler, MMB
    Bots, ML
    Ott, A
    Hofman, A
    HAEMOSTASIS, 1998, 28 (3-4) : 167 - 173
  • [26] INITIATION OF LEVODOPA THERAPY IN PARKINSONIAN-PATIENTS SHOULD BE DELAYED UNTIL THE ADVANCED STAGES OF THE DISEASE
    MELAMED, E
    ARCHIVES OF NEUROLOGY, 1986, 43 (04) : 402 - 405
  • [27] PLASMA LEVODOPA, DOPAMINE AND THERAPEUTIC RESPONSE FOLLOWING LEVODOPA THERAPY OF PARKINSONIAN-PATIENTS
    ROSSOR, MN
    WATKINS, J
    BROWN, MJ
    REID, JL
    DOLLERY, CT
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1980, 46 (03) : 385 - 392
  • [28] Intensive risk factor control reduces cardiovascular events in patients with peripheral vascular disease
    Lafitte, M.
    Pillois, X.
    Richeboeuf, V.
    Boulon, C.
    Bonnet, J.
    Couffinhal, T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 71 - 71
  • [29] Risk factors and outcomes for patients with vascular disease and serious bleeding events
    Alberts, Mark J.
    Bhatt, Deepak L.
    Smith, Sidney C., Jr.
    Roether, Joachim
    Goto, Shinya
    Hirsch, Alan T.
    Steg, Ph Gabriel
    HEART, 2011, 97 (18) : 1507 - 1512
  • [30] Peripheral vascular disease risk factors among patients undergoing hemodialysis
    O'Hare, AM
    Hsu, CY
    Bacchetti, P
    Johansen, KL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 497 - 503
12345